Immune checkpoint inhibitor (ICI)-mediated myocarditis is a rare but devastating side effect of cancer immunotherapy with up to 40% mortality and long-term cardiac issues such as arrhythmias and heart failure in affected patients. Recently, Axelrod et al. suggested an auto-antigen-driven mechanism as the immunological basis for this disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.medj.2022.12.005 | DOI Listing |
Publication Analysis
Top Keywords
immune checkpoint
8
potential auto-antigen-guided
4
auto-antigen-guided treatment
4
treatment immune
4
checkpoint inhibitor-mediated
4
inhibitor-mediated myocarditis
4
myocarditis immune
4
checkpoint inhibitor
4
inhibitor ici-mediated
4
ici-mediated myocarditis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!